Public-domain · open source
OpenJurist
← 871 F.2d 409 - United States v. 225 Cartons, More or Less, of an Article or Drug

United States v. 225 Cartons, More or Less, of an Article or Drug’s Empirical Analysis

871 F.2d 409 · 1989

Citation profile

58
cited by 58 later decisions
1
states following
August 2016
most recently cited

9 federal appellate · 40 district · 1 state decisions

How this case has been cited

Cited by 58 later decisions — most recently August 2016 · most notably United States v. Four Parcels of Real Property in Greene & Tuscaloosa Counties (1991), Commonwealth v. Fall River Motor Sales, Inc. (1991)

9 federal appellate · 40 district · 1 state decisions

4701989199020002010decided

Later decisions citing this case, by decade. The current decade is in progress, and our corpus holds fewer opinions from the most recent years, so the latest bars are undercounted — not a real decline.

Relationships

Applies 21 U.S.C. § 301 (Animal Drug Amendments of 1968) · 21 U.S.C. § 321 (Federal Food, Drug, and Cosmetic Act) · 21 U.S.C. § 355 (Federal Food, Drug, and Cosmetic Act) · 28 U.S.C. § 1746

Relies on Anderson v. Liberty Lobby, Inc. · Robertson v. Methow Valley Citizens Council · Weinberger v. Hynson, Westcott & Dunning, Inc. · National Labor Relations Board v. International Longshoremen's Ass'n · Weinberger v. Bentex Pharmaceuticals, Inc.

Most-quoted passages

The sentences later courts lift from this opinion, ranked by how many decisions quote each — the parts of the opinion doing the work. These counts are smaller than the citation total above because most of the 58 citing decisions cite the case generally; a passage count includes only decisions quoting that exact language verbatim.

  1. “Under the Hynson decision, supra, the evidentiary standards for effectiveness required for a new drug application under 21 U.S.C. § 355 (d) must also be applied to any drug for which “general recognition of effectiveness among experts” is claimed under § 321(p). Section 355(d)(5) requires that an application be rejected if the FDA finds a “lack of substantial evidence that the drug will have the effect it purports to have.” Substantial evidence is defined in the same subsection as “evidence consisting of adequate and well-controlled investigations, [conducted] by experts.””
    1 later decision quote this exact passage · from the majority

How this case has been treated — in progress

Whether each later court followed, distinguished, criticized, or overruled this decision. The treatment classification (task #35) runs highest-cited cases first and lights up here as it reaches this one.